Related Experiment Video
Updated: Apr 17, 2026

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
[Chronic thromboembolic pulmonary hypertension].
Developments in chronic thromboembolic pulmonary hypertension (CTEPH) include updated diagnostic guidance and new treatment data. Pulmonary endarterectomy remains the primary treatment for operable CTEPH, with expanded options for other patients.
Area of Science:
- Cardiology
- Pulmonology
- Vascular Medicine
Context:
- Significant advancements in understanding and managing chronic thromboembolic pulmonary hypertension (CTEPH) have emerged since 2008.
- Technological progress and new clinical data are refining diagnostic and therapeutic strategies.
Purpose:
- To provide an overview of key developments in CTEPH presented at the 2013 World Symposium on Pulmonary Hypertension.
- To highlight updated guidance on diagnosis, treatment outcomes, and emerging therapies for CTEPH.
Summary:
- Updated guidelines enhance the recognition and diagnosis of pulmonary hypertension, particularly CTEPH.
- New data covers international treatment practices, long-term outcomes, medical therapies, and percutaneous pulmonary angioplasty for CTEPH.
- Pulmonary endarterectomy is confirmed as the preferred treatment for operable CTEPH, with growing international experience.
Impact:
- Improved diagnostic accuracy and timeliness for CTEPH patients.
- Expanded therapeutic options, including medical management and interventional procedures.
- Enhanced understanding of long-term outcomes for various CTEPH treatment strategies.
More Related Videos
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
06:59Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Pulmonary Embolism I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Chronic Obstructive Pulmonary Disease-I: Introduction